Atai Life Sciences (ATAI) News Today $1.99 -0.05 (-2.45%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.98 0.00 (-0.25%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period atai Life Sciences Completes $63.25 Million Public Offering to Advance Mental Health Treatment InitiativesFebruary 22 at 12:59 AM | nasdaq.comAtai Life Sciences announces full exercise of option to purchase sharesFebruary 20 at 9:55 PM | markets.businessinsider.comPsilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent PortfolioFebruary 20 at 11:53 AM | finance.yahoo.comatai Life Sciences completes public offering, raising $63.25MFebruary 20 at 9:20 AM | proactiveinvestors.comatai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common SharesFebruary 20 at 7:00 AM | globenewswire.comatai Life Sciences announces pricing of $55M public offering of sharesFebruary 13, 2025 | proactiveinvestors.comAtai Life Sciences: Promising Pipeline and Upcoming Catalysts Drive Buy RatingFebruary 13, 2025 | tipranks.comAtai Life Sciences 26.2M share Spot Secondary priced at $2.10February 13, 2025 | markets.businessinsider.comatai Life Sciences Announces Pricing of Public Offering of Common SharesFebruary 12, 2025 | globenewswire.comAtai Life Sciences announces $55M common shares offeringFebruary 12, 2025 | markets.businessinsider.comatai Life Sciences unveils $55M public offering to advance mental health treatmentsFebruary 12, 2025 | proactiveinvestors.comatai Life Sciences Announces Proposed Public Offering of Common SharesFebruary 12, 2025 | globenewswire.comAtai CEO Rao optimistic about psychedelic therapies despite Lykos setbackFebruary 11, 2025 | msn.comatai Life Sciences CEO discusses success of BPL-003 alcohol use disorder trial - ICYMIFebruary 8, 2025 | proactiveinvestors.comatai Life Sciences-backed psychedelic drug could offer superior value, analysts believeFebruary 6, 2025 | proactiveinvestors.comH.C. Wainwright Keeps Their Buy Rating on ATAI Life Sciences (ATAI)February 5, 2025 | markets.businessinsider.comatai Life Sciences gains as new data derisks upcoming treatment-resistant depression trial readoutFebruary 3, 2025 | proactiveinvestors.comTD Cowen Reaffirms Their Buy Rating on ATAI Life Sciences (ATAI)January 31, 2025 | markets.businessinsider.comAtai Life Sciences And 2 Other Promising Penny Stocks On US ExchangesJanuary 31, 2025 | finance.yahoo.comPsychedelic: atai Life Sciences reports BPL-003 study resultsJanuary 30, 2025 | markets.businessinsider.comAtai Life Sciences: Positive BPL-003 Data In AUD Leads To Another CatalystJanuary 29, 2025 | seekingalpha.comBPL-003 shows promise in alcohol use disorder studyJanuary 28, 2025 | msn.comAtai reports positive data for psychedelic drug BPL-003January 28, 2025 | msn.comAtai Life Sciences announces results from BPL-003 Phase 2a open-label studyJanuary 28, 2025 | markets.businessinsider.comATAI Life Sciences Rated Buy by Patrick Trucchio: Promising Phase 2a Trial Results and Favorable Valuation AnalysisJanuary 28, 2025 | markets.businessinsider.comatai Life Sciences poised for near-term value creation with release of psychedelics trial data: analystsJanuary 28, 2025 | proactiveinvestors.comatai Life Sciences unveils positive results from Beckley Psytech's alcohol use disorder trialJanuary 28, 2025 | proactiveinvestors.comSpravato sales surged highlights commercial viability of psychedelics, analysts believeJanuary 27, 2025 | proactiveinvestors.comATAI Life Sciences supervisory board member resignsJanuary 24, 2025 | msn.comAtai Life Sciences appoints Rao as CEO, other key appointmentsJanuary 10, 2025 | markets.businessinsider.comAtai Life Sciences Appoints Gerd Kochendoerfer As COO; Srinivas Rao Assumes Sole CEO RoleJanuary 10, 2025 | markets.businessinsider.comatai Life Sciences announces leadership appointments to advance psychedelic therapeutics pipelineJanuary 10, 2025 | proactiveinvestors.comAtai Life Sciences says Srinivas Rao assumes role of sole CEOJanuary 10, 2025 | seekingalpha.comatai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental HealthJanuary 10, 2025 | globenewswire.comAtai Life Sciences price target lowered to $10 from $15 at H.C. WainwrightNovember 19, 2024 | markets.businessinsider.comATAI Life Sciences: Buy Rating Affirmed Amid Promising Pipeline and Financial EfficiencyNovember 19, 2024 | markets.businessinsider.comATAI Life Sciences: Strategic Advancements and Strong Financials Underpin Buy RatingNovember 17, 2024 | markets.businessinsider.comAtai Q3 Report: Strong Cash Position, Clinical Pipeline GrowthNovember 14, 2024 | benzinga.comTD Cowen Sticks to Its Buy Rating for ATAI Life Sciences (ATAI)November 14, 2024 | markets.businessinsider.comatai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNovember 14, 2024 | finance.yahoo.comAtai Life Sciences Advances Psychedelic Treatments in Q3 2024November 14, 2024 | markets.businessinsider.comatai Life Sciences shares set to be lifted by 2025 trial data readouts: analystsNovember 14, 2024 | proactiveinvestors.comatai Life Sciences advances therapeutic pipeline in Q3 with FDA approval of VLS-01November 13, 2024 | proactiveinvestors.comRFK Jr's appointment in health could accelerate psychedelic drug development, analysts sayNovember 12, 2024 | proactiveinvestors.comMassachusetts psychedelics legalization initiative poised to failNovember 6, 2024 | msn.comATAI Life Sciences (NASDAQ:ATAI) Stock, Insider Trading ActivityOctober 15, 2024 | benzinga.comatai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 15, 2024 | finance.yahoo.comCould Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says YesOctober 8, 2024 | benzinga.comATAI Life Sciences completes acquisition of IntelGenx Corp.October 6, 2024 | investing.comIntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AGOctober 2, 2024 | globenewswire.com Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼0.660.60▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼62▲ATAI Articles Average Week Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARQT News Today AMPH News Today IMCR News Today KNSA News Today DYN News Today GPCR News Today ARDX News Today INDV News Today NRIX News Today VIR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free atai Stock Alerts